DAX22.540 +1,7%ESt505.320 +1,4%Top 10 Crypto12,16 +3,2%Dow41.990 ±-0,0%Nas17.450 +0,9%Bitcoin78.817 -0,1%Euro1,0792 ±-0,0%Öl74,45 -0,1%Gold3.122 +0,4%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Tesla A1CX3T Rheinmetall 703000 NVIDIA 918422 RENK RENK73 thyssenkrupp 750000 Novo Nordisk A3EU6F Lufthansa 823212 Mercedes-Benz Group (ex Daimler) 710000 HENSOLDT HAG000 Amazon 906866 Volkswagen (VW) vz. 766403 Commerzbank CBK100 Siemens Energy ENER6Y Deutsche Telekom 555750 BASF BASF11
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Trump-Zölle weiter im Fokus: Dow schlussendlich stabil -- DAX schließt erholt -- Zollkonflikt könnte Deutschland in Rezession treiben -- TUI, Rheinmetall, China-Internetaktien, Newsmax im Fokus
Top News
Freundlicher Handel: S&P 500 zum Handelsende mit Zuschlägen Freundlicher Handel: S&P 500 zum Handelsende mit Zuschlägen
Schwache Performance in New York: Dow Jones letztendlich im Minus Schwache Performance in New York: Dow Jones letztendlich im Minus
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Wer­bung
"600% Momentum-Strategie": Aktien hebeln und Gewinne maximieren - sichern Sie sich jetzt das Kennenlernangebot für nur 39 Euro (statt 69 Euro) im Monat!

Insmed Aktie

NeuKaufenVerkaufen
Insmed Aktien-Sparplan
68,50 EUR -1,50 EUR -2,14 %
STU
72,38 USD +0,37 USD +0,51 %
nachbörslich
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.12,79 Mrd. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA1JJA3

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS4576693075

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolINSM

Insmed Aktien News

DatumMeistgelesen
PR NewswireInsmed To Present at Three March Conferences
PR NewswireInsmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update
PR NewswireInsmed to Host Fourth-Quarter and Full Year 2023 Financial Results Conference Call on Thursday, February 22, 2024
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed To Present at the 42nd Annual J.P. Morgan Healthcare Conference
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed To Present at the Nasdaq 49th Investor Conference
PR NewswireInsmed To Present at Two November Conferences
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed Holds Second Annual Global Day of Good to Benefit Communities Across the Globe
PR NewswireInsmed Ranks No. 1 on Science's 2023 Top Biopharma Employers List
PR NewswireInsmed Reports Third-Quarter 2023 Financial Results and Provides Business Update
PR NewswireInsmed and Google Cloud Collaborate to Transform the Lives of Patients by Harnessing the Power of AI
PR NewswireInsmed to Host Third-Quarter 2023 Financial Results Conference Call on Thursday, October 26, 2023
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed To Present at Chardan's 7th Annual Genetic Medicines Conference
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed To Present at the Morgan Stanley 21st Annual Global Healthcare Conference
PR NewswireINSMED ANNOUNCES POSITIVE TOPLINE RESULTS FROM PHASE 3 ARISE STUDY OF ARIKAYCE® (AMIKACIN LIPOSOME INHALATION SUSPENSION) IN PATIENTS WITH NTM LUNG DISEASE CAUSED BY MAC
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed Reports Second-Quarter 2023 Financial Results and Provides Business Update
PR NewswireInsmed to Host Second-Quarter 2023 Financial Results Conference Call on Thursday, August 3, 2023
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed To Present at the Goldman Sachs 44th Annual Global Healthcare Conference
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed Presents Range of New Study Findings at American Thoracic Society 2023 International Conference
PR NewswireInsmed Unveils New Research Platforms and Capabilities at Investor and Analyst Event, "The Future of Rare at Insmed: Functional Genes, AI-Enhanced Proteins, Glowing Algae, and More"
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed Reports First Quarter 2023 Financial Results and Provides Business Update
PR NewswireInsmed to Host Investor and Analyst Event on May 8, 2023
PR NewswireInsmed to Host First Quarter 2023 Financial Results Conference Call on Thursday, May 4, 2023
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis
PR NewswireInsmed to Present New Clinical, Pre-Clinical, and Real-World Data in Serious and Rare Lung Diseases at the American Thoracic Society 2023 International Conference
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed To Present at Two March Conferences
PR NewswireInsmed Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
PR NewswireInsmed to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call on Thursday, February 23, 2023
Wer­bung

Insmed News

Insmed News: auf dieser Seite finden Sie alle Insmed News und Nachrichten zur Insmed Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Insmed News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Insmed News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.